Product Specifications:
Item# 1021: Recombinant HIV-1 MN Envelope Glycoprotein gp120 (Baculovirus).
Concentration: See vial
Mass/vial: 100ug
Diluent: PBS
Purity: >95%
Stabilizer: None
Preservative: None
Storage: -75°C
Physical State: Frozen
Liquid Stability: At least 24 months at -75°C.
Applications: Human diagnostics, CD4 binding, Drug screening, Human T-cell CD4 studies.
Description: Gene cloned from T-cell-tropic HIV-1 MN strain and the full length recombinant envelope gp120 glycoprotein produced in the Baculovirus Expression System.
Purification: This protein is purified by immuno-affinity chromatography to >95% purity as determined by SDS-PAGE, reduced.
Specificity: This protein binds to murine monoclonal antibodies of defined epitope specificity and HIV-1 converted human serum polyclonal antibodies in ELISA and Western ELISA.
Biological Activity: This protein binds to human T-cell receptor CD4 in ELISA and Western ELISA as determined by CD4/gp120/Anti gp120 mAb-peroxidase capture ELISA. This protein activates human T-Lymphocytes (CD4+, CD4-), in vitro, as measured by RNA synthesis during G0 to G1 transition phase of antigen-binding competent cells.
Application and Instructions for use:
Recommended concentrations for use are approximate values. A dose dependent response assay should be performed to determine the optimal concentration for use in specific applications. ELISA and Western ELISA require 10-100ng protein depending on the nature and affinity of the detection reagent. Human serum polyclonal antibodies yield titers of 1:1000 or greater at 10-100ng of immobilized protein under standard ELISA conditions.
Related Clinical Trials
| Official Title: | A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults |
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults
Intervention:
Biological: MN rgp120/HIV-1 and A244 rgp120/HIV-1, QS-21, rgp120/HIV-1MN
Group 1: low-dose MN rsgp120/HIV-1 plus QS-21 (13 volunteers). Group 2: high-dose MN rsgp120/HIV-1 plus QS-21 (13 volunteers). Group 3: AIDSVAX B/E (injection contains each of the two vaccine components, HIV-1 MN rgp120 and A244 rgp120/HIV-1) plus QS-21 plus alum (13 volunteers).
Group 4: high-dose MN rgp120/HIV-1 plus QS-21 plus alum (13 volunteers). Group 5: placebo plus QS-21 (8 volunteers). Volunteers will be closely monitored after each immunization and followed for a minimum of 12 months after the initial immunization.
ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
>
雷士超声波清洗机主要应用于医院手术刀、镊子、止血钳、内镜活检钳、注射用针头、各式大小注射器、试管、玻璃瓶、玻璃片、换药碗、各种盘子、圆桶等放射性、污染性器具的大批量高洁度的清洗和消毒，是医院手术室、化验室、检验室、供应室、牙科、消毒中心以及科研单位，制药厂的必备设备。
Ultrasonic cleaning machine using process
超声波清洗机使用流程
Ultrasonic cleaning machine using process
使超声波清洗效果最佳的方式
(1)超声波清洗机槽的温度最好为30~50℃。
(2)根据不同的清洗对象正确选择清洗剂。清洗剂一般分为水基(碱性)清洗剂、有机溶剂清洗剂和化学反应清洗剂。通常使用最多的为水基清洗剂。
(3)根据被清洗物的污染程度和污垢性质，选用不同的清洗时间。超声波清洗机的清洗液可以循环使用，这种清洗方式可以节约大量的清洗液，每次使用完清洗机后，最好将清洗液放入容器中，下次使用时再倒入清洗槽，余下的沉淀物可处理掉。如清洗液的浓度不够时，适量加入一点即可重复使用。
超声波清洗机使用的是一种非常严密的清洗工艺，因此，超声波清洗机和清洗液的选择也是非常关键的，这直接影响着清洗的效果如何。所以，我们在购买清洗设备之前，就需要对被清洗部件做分析。
首先，我们需要明确被清洗对象的材料构成、结构以及数量，进而来分析并明确要清除的污染物，这些因素都是决定所要使用什么样的清洗液。通过分析我们就可以判断出是用溶剂清洗液还是用水性清洗液。
其次，最终的清洗工艺选择还需做清洗实验来证实哪一种才是最为合适的。只有这样，才能提供合适的超声波清洗机、设计合理的清洗工序以及清洗液来进行清洗作业 。
最后需要考虑清洗液的物理特性对超声波清洗机的影响，其中表面张力、蒸汽压、密度以及黏度是最明显的影响因素。除此之外，温度也是影响因素之一，通常也会影响空化作用的效率。
总而言之，要想使超声波清洗机达到理想的清洗效果和目标，在清洗之前作必要的分析是非常必要的，是必不可少的重要环节。
上海浸泰专注碳氢清洗机16年！
铭扬超声波清洗机小编为您解答：超声波清洗机的power99%是你机台额定功率的百分比，意思就是机台额定功率是1000W，power99%显示现在机台工作功率达到了990W
